Health care budgets are stretched by the growth in chronic disease in an ageing population and meeting consumer expectations for better access to tests, treatments and devices.

At the same time there is an increase in the rate of medical tests, treatments and device innovation and improvement.

This is resulting in the need for timely expert evidence and cost effectiveness studies to inform the  careful investment choices for medical research institutes, health systems, health funders and universities.

Examples of projects we have supported include:

• We have worked with the Office for Health and Medical Research (OHMR) for a number of years to monitor and evaluate the outcomes of various grant schemes including the Medical Devices Fund (MDF) and Medical Research Support Program (MRSP).
• Immune Effector Cell Therapy Services Plan for NSW Ministry of Health
• Cost effectiveness robotic surgery SWSLHD
• Development of funding applications for new technologies. This has included market analysis (including market size estimation), competitor analysis, development of the optimal operational model (revenue, costs and staffing) and measurement of the economic benefits of the proposed service.

Services provided have included:

• The preparation of business plans and financial projections
• Infrastructure development plans and funding strategies
• Preparation of grant and funding applications
• Evaluation of the efficiency and ongoing sustainability of the institute

• Strategic reviews.
• Developing financial models to assist with the analysis of strategic options.

This process involves the development of financial models to assist with the analysis of strategic options.